Just two miles short of the finish line of the 2026 New York City Marathon on Nov. 1, 24-year-old runner Rachel Apa collapsed. She died of a rare and potentially life-threatening illness that can be brought on by excessive exertion, the New York Times reported.
It's called rhabdomyolysis, and while there are relatively few cases nationwide each year, it can strike during endurance or intensive exercise, including marathons.
Apa was running her first marathon to raise money for Parkinson's disease in honor of her late grandfather, according to the New York Times. But Apa was no stranger to athletics, having played Division I field hockey in college. Her family said Apa had been in "perfect health." Plus, she'd been training for the race for months.
But at mile 18, Apa texted her father, Steve, who'd been checking in at each mile: "Ow." At the end of the next mile, she wrote, "Ow ow." She stopped responding after that. Apa's mother, Michelle, was at the race and had watched her daughter run by earlier on. Her parents noticed on the marathon tracking app that Apa stopped moving after mile 24.
Apa collapsed just after running past hospital social worker Michaela Nichols, who was cheering on participants. Nichols ran over and checked Apa's pulse, but couldn't find one. Three other people — two of whom said they were physicians — ran over to give Apa CPR. Marathon medical staff tried to revive her with a defibrillator before an ambulance arrived. She was taken to Mount Sinai Medical Center and treated for six hours, but could not be saved.

#year #collapsed

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below.
Despite the ongoing affordability and cost-of-living crisis, Americans are trying to save as much money as possible for retirement. According to Fidelity's latest report, (1) the average savings rate for a 401(k) participant hit a record high of 14.4% (employee and employer contributions combined) in the second quarter of 2026.
Despite this ferocious pace of savings, many older Americans are anxious about their retirement prospects. In fact, 75% of pre-retirees over the age of 50 told F&G Annuities & Life (2) they were considering or had already delayed their retirement as of 2026.
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one
A single line on your car insurance policy could be inflating your premium by up to 30% — here's what to change

#Retirement #savings #according #life

The Kansas City Chiefs might be without rookie defensive back Mansoor Delane during their Week 8 matchup against the Denver Broncos.
Delane — who joined Kansas City as the No. 6 pick in the 2026 NFL Draft — is said to be dealing with a shoulder injury and was a non-participant in the Chiefs' practice session on Thursday, October 29.
It is unclear if Delane will need to miss any time due to his condition, but fans in Kansas City should monitor the first-year standout's progress throughout the week to see if the Chiefs ****** ign him an official game status designation for the team's AFC West tilt with Denver.
Here's Thursday's injury report for the Chiefs and Broncos. pic.twitter.com/55v5UZ9Y2T
A former LSU Tigers star, Delane has been among Kansas City's most impressive defenders this year and is expected to develop into a franchise player for the Chiefs as his NFL career progresses.

#kansas #injury

Tampa Bay Buccaneers QB Baker Mayfield (thumb) was a full participant in practice Thursday, Oct. 29.
SOURCE: Buccaneers.com
Why it Matters: Mayfield returned to action in Week 7, but he only had to throw 11 times as the Buccaneers cruised to a win. He wasn't posting great numbers prior to the injury, so it wouldn't be wise to expect Mayfield to suddenly start delivering great stat lines. For now, he should be considered a QB2.
This article originally appeared on USA TODAY: Full practice for Baker Mayfield Thursday

#mayfield #baker #thursday

The Tennessee ***** ans' leading receiver this season, rookie Carnell Tate, has missed consecutive days of practice because of a shoulder injury ahead of a Week 8 matchup with the Cincinnati Bengals.
Also among those not practicing Thursday according to the ***** ans' injury report were running backs Tyjae Spears (knee) and Tony Pollard (rest), and punter Tommy Townsend (knee).
Receiver Calvin Ridley (hip) and DL John Franklin-Myers (groin) were limited.
Tate, the fourth overall pick in the 2026 NFL Draft from Ohio State, leads the ***** ans with 34 catches and 413 receiving yards through seven games. He has scored one touchdown, and fumbled three times (two lost).
Bengals receiver Ja'Marr Chase, a non-participant Thursday for practice, was a full participant Thursday. Safety Jordan Battle (hamstring) was limited.

#injury #limited

The Tennessee ******* ans' leading receiver this season, rookie Carnell Tate, has missed consecutive days of practice because of a shoulder injury ahead of a Week 8 matchup with the Cincinnati Bengals.
Also among those not practicing Thursday according to the ******* ans' injury report were running backs Tyjae Spears (knee) and Tony Pollard (rest), and punter Tommy Townsend (knee).
Receiver Calvin Ridley (hip) and DL John Franklin-Myers (groin) were limited.
Tate, the fourth overall pick in the 2026 NFL Draft from Ohio State, leads the ******* ans with 34 catches and 413 receiving yards through seven games. He has scored one touchdown, and fumbled three times (two lost).
Bengals receiver Ja'Marr Chase, a non-participant Thursday for practice, was a full participant Thursday. Safety Jordan Battle (hamstring) was limited.

#Titans #bengals #practice

Tampa Bay Buccaneers WR Emeka Egbuka (concussion, foot) was a limited participant in practice Thursday, Oct. 29.
SOURCE: Buccaneers.com
Why it Matters: Egbuka remained a limited participant, so he still isn't a lock to return to action this weekend. He was piling up targets prior to missing the Week 7 contest, so if he does suit up, WR3 production is certainly in play.
This article originally appeared on USA TODAY: Another limited practice for Emeka Egbuka

#egbuka #limited #emeka #matters

Seattle Seahawks RB Jadarian Price (chest) was a limited participant in practice Thursday, Oct. 29.
SOURCE: Seahawks.com
Why it Matters: Price has a chance to return to action Monday night, but with Zach Charbonnet (knee) potentially making his debut and Emanuel Wilson and George Holani also in the mix, it is going to be hard to know which Seattle back to trust. Fantasy owners with more reliable options should probably shy away from the Seattle backfield until a pecking order becomes better established.
This article originally appeared on USA TODAY: Jadarian Price remains limited Thursday

#seahawks #thursday #zach

Buccaneers' Emeka Egbuka among players included in latest injury report before Falcons game appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
Tampa Bay Buccaneers wide receiver Emeka Egbuka is showing signs of progress in his recovery, although his status for Sunday's Week 8 clash with the Atlanta Falcons remains up in the air.
Egbuka was a limited participant in Thursday's practice as he continued to work through the NFL's concussion protocol. One encouraging sign was his return to a regular practice jersey after previously wearing a non-contact one. The development suggests he is making progress, though he still needs medical clearance before returning to game action.
The rookie has been out since sustaining a concussion and a foot injury in the Buccaneers' Week 6 loss to the Pittsburgh Steelers. During the fourth quarter, Steelers linebacker Patrick Queen delivered a hit that brought his shoulder into Egbuka's helmet as the receiver tried to make a play on an incomplete pass. The injuries forced him to sit out Tampa Bay's Week 7 win over the Carolina Panthers.
Watch sports LIVE with fuboTV (free trial)

#buccaneers #egbuka #week #tampa

Girls flag football is now a sanctioned varsity sport in the state of Oregon. The Delegate **** embly of the Oregon School Activities **** ociation unanimously voted to sanction girls flag football during its Monday, Oct.12 meeting. This makes Oregon the 25th state to recognize girls flag football as an official sport.
Oregon joined fellow western states Arizona, California, Nevada and Washington in sanctioning the sport.
Girls flag football debuted in Oregon as an emerging activity during the spring of 2023 with 57 high school programs competing as of the 2026 spring season. The sport will begin its inaugural season as a sanctioned activity in spring 2027. Flag Football is the second sport approved by the OSAA through its emerging activity process. Boys volleyball was the first, in 2025-26.
According to the OSAA website, there are 30 teams listed as full participants for the upcoming 2027 girls flag football season. So far there are no Cowapa League teams on the list.
There are seven 4A schools and two 3A schools, with the rest being from 5A and 6A.

#flag #girls #spring

Los Angeles Chargers WR Ladd McConkey (concussion) was a full participant in practice Thursday, Oct. 29.
SOURCE: Chargers.com
Why it Matters: McConkey has been battling a variety of injuries since the season opener, but ****** uming he clears concussion protocol, it looks like he could be relatively healthy for the Week 8 contest against the Los Angeles Rams. Granted, the Chargers' offense been struggling to find a rhythm, but McConkey can be a WR3.
This article originally appeared on USA TODAY: Ladd McConkey a full participant Thursday

#full

Kansas City Chiefs QB Patrick Mahomes (knee) was a full participant in practice Thursday, Oct. 29.
SOURCE: Chiefs.com
Why it Matters: Mahomes has failed to throw a touchdown pass in each of his last two games, and with Travis Kelce (ankle) and Rashee Rice (hamstring, knee) both battling injuries, he could be without two of his main weapons. Mahomes is shaping up to be a QB2 in Week 8.
This article originally appeared on USA TODAY: Patrick Mahomes practices in full

#city

Kansas City Chiefs WR Rashee Rice (hamstring, knee) was a limited participant in practice Thursday, Oct. 29.
SOURCE: Chiefs.com
Why it Matters: With Rice remaining a limited participant, his status for the Week 8 game against the Denver Broncos is still unclear. If he does suit up, he should immediately resume his role as the No. 1 target in the passing game.
This article originally appeared on USA TODAY: Rashee Rice remains limited Thursday

#rice #limited #participant

Kansas City Chiefs TE Travis Kelce (ankle) was a limited participant in practice Thursday, Oct. 29.
SOURCE: Chiefs.com
Why it Matters: Kelce was a full participant Wednesday, so it is a little concerning to see his status head in the wrong direction. He can be a low-end TE1 if he suits up, but Kelce's status for Friday's practice will be telling.
This article originally appeared on USA TODAY: Travis Kelce limited during Thursday's practice

#kelce #practice #participant #city

Denver Broncos WR Jaylen Waddle (chest) was a limited participant in practice Thursday, Oct. 29.
SOURCE: DenverBroncos.com
Why it Matters: Waddle managed a limited practice after missing Wednesday's session, so if he continues to progress, there is a chance he could play in Week 8. That being said, Waddle has reached 50 receiving yards just once in seven games this season. It is hard to expect him to provide more than WR4 production.
This article originally appeared on USA TODAY: Jaylen Waddle a limited participant Thursday

#waddle #jaylen #thursday #participant

Denver Broncos RB RJ Harvey (knee) was a limited participant in practice Thursday, Oct. 29.
SOURCE: DenverBroncos.com
Why it Matters: Harvey wasn't listed on Wednesday's practice report, so the injury is something worth monitoring heading into Friday's session. His role in the offense has been shrinking a bit with the emergence of Jonah Coleman, and while Harvey has remained involved in the passing game, he has largely been reduced to a big-play dependent flex option.
This article originally appeared on USA TODAY: RJ Harvey pops up on Thursday's practice report

#denver #thursday

Arizona Cardinals RB Jeremiyah Love (ankle) was a limited participant in practice Thursday, Oct. 29.
SOURCE: AZCardinals.com
Why it Matters: With Love remaining limited, his status for the Week 8 contest remains in question. Friday's injury report will be a better indicator, but if Love is able to return to action, he can be a RB2 against the Cowboys.
This article originally appeared on USA TODAY: Jeremiyah Love remains limited

#arizona #azcardinals

Washington Commanders WR Stefon Diggs (hamstring, hand) fully participated in practice Thursday, Oct. 29.
SOURCE: Commanders.com
Why It Matters: Diggs missed the first practice of the week but was a full participant Thursday and is set to play in Week 8. He will be the team's main receiver for the rest of the season and can be at least a No. 3 receiver in fantasy leagues.
This article originally appeared on USA TODAY: Stefon Diggs fully takes part in practice

#Commanders #thursday

Minutes from the Federal Reserve's September policy meeting reflect unanimous agreement among officials that interest rates needed to be higher to combat persistent inflation.
"Participants generally emphasized that inflation remained elevated while the labor market appeared to be near full employment, with some signs of strengthening, and that economic activity was expanding at a solid pace. Furthermore, almost all participants ****** sed that, while inflation risks were tilted to the upside, risks to the labor market had diminished and were now broadly balanced," minutes from the Sept. 16 meeting released Wednesday stated.
"Based on the outlook and the changing balance of risks, all participants viewed a higher target range for the federal funds rate as appropriate."
The Fed voted unanimously on Sept. 16 to raise rates, the first hike in three years. And at the time, most Federal Open Market Committee members saw a need for at least one more 25 basis point rate hike this year.
Markets were banking on a hike and expecting more to come.

#federal #hike #rates

It's common for new investors to want to hit home runs in their first at-bats. That situation is arguably amplified at a time when major equity indexes are regularly hitting record highs.
With glamorous, high-octane growth stocks leading the charge, some market participants may be losing sight of the value of the singles-and-doubles approach to dividend investing. Those investors shouldn't ignore history. Though the percentage trended lower over the past decade due to the prominence of low-yield and non-dividend tech darlings, dividends accounted for about a third of the S&P 500's total returns over the past century.
Missed AI's "Act 1"? Act 2 Could Be 14x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our ******* ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Most investors don't think in 100-year increments, and that's understandable, but when it comes to dividend investing, history and long-term perspectives matter. And the Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD) is a prime example of a dividend exchange-traded fund (ETF) with a compelling history for long-term investors.
Locked in a seemingly daily battle with the Vanguard Dividend Appreciation ETF for the ******* le of the largest dividend ETF, the $108 billion Schwab fund has a nearly unmatched track record. Two weeks shy of its 15th birthday, this ETF, which tracks the Dow Jones U.S. Dividend 100 Index, has returned 532% since its launch.

#investors

It's clear that the Princess of Wales has entered her autumn style era. Now that October is upon us, the 44-year-old has embraced the seasonal change with a plethora of darker-toned items.
Last week, Kate hosted a secret tea party for Three Peaks Challenge participants and their families at Windsor Castle. The royal looked elegant in a chocolate brown-coloured belted dress by the famously English heritage label Burberry. The structured fit-and-flare silhouette offered a clean, monochromatic look.
A new item in Kate's wardrobe, the £1,760 tailored dress is cut in a fit-and-flare silhouette that's cinched in with a striking, gold twist-lock belt. It also has slip pockets, which Kate was spotted appearing to use at certain moments. The dress appears to be bespoke as the sleeves are three-quarter length, whereas the frock on the shelves featured capped sleeves.
The Princess of Wales hosted a very special tea party at Windsor Castle (@ Andrew Parsons / Kensington Palace)
A year earlier, Kate wore the very same dress, but in black. During the German State visit in 2025, the mother of three was pictured viewing exhibits from the Royal Collection relating to Germany in the Green Drawing Room at Windsor Castle, alongside her husband, Prince William.

#kate #castle #dress #hosted

Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built for investors.
There's a lot we can't predict, like the outcome of the midterm elections, who will make it to the Super Bowl or whether Taylor Swift was actually hinting at a new album release in that Emmy's sketch. But when it comes to what our retirement looks like, we can certainly try.
Many retirement plans offer predictive tools that can help savers forecast their future balances, retirement readiness, income replacement rates and more. Participants, however, aren't happy with the options: J.D. Power's recent survey of digital experience satisfaction for retirement plans found that predictive tools were the lowest-performing attribute.
"The technology in the 401(k) is seriously behind what people are used to in their consumer life," said Fred Barstein, CEO of The Retirement Advisor University. When the underlying technology structure is old and **** bersome, it's hard for the tools to be as effective as they could be.
Sign up for The Daily Upside at no cost for premium **** ysis on all your favorite stocks.

#tools #sign #upside #like

Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built for investors.
A mind is a terrible thing to waste, but college is awfully expensive.
Depending on where someone goes to school, they can be left with a lot of debt — an albatross that can hang around their neck for decades. Among 401(k) plan participants in their 40s, those with student loan debt had median retirement account balances roughly 45% lower than those without, according to a new report from the Employee Benefit Research Institute.
The best option is to figure out scholarships, financial aid, debt timelines and what school makes financial sense before going to college. But that's not reality for many clients, leaving advisors to help fit student debt into a financial plan that balances both loans and savings. "The biggest mistake I see is treating student loans as an all-or-nothing problem," said Corinna Rose, a CFP with Bell Investment Advisors. "Many borrowers think they need to eliminate every dollar of debt before they can start investing."
Sign up for The Daily Upside at no cost for premium ******* ysis on all your favorite stocks.

#student #sign #many

The name "351 Exchange" comes from Section 351 of the Internal Revenue Code ("IRC"). Section 351 permits a person to contribute appreciated property in exchange for shares of a newly formed corporation without recognizing a taxable event at the time of transfer, if certain rules are met.
In this application, the property being contributed is shares of stock or ETFs, in exchange for shares of a newly formed corporation, a new ETF.
To qualify, here are a few rules:
1) The contributor must be an eligible participant. In short, most can participate, but C corporations can cause issues, so they are generally excluded.
2) Each contributor must contribute a diversified portfolio. Diversification is defined by the IRS with two tests applied to each contributor's portfolio: Of the contributed portfolio, (1) the weight of the largest position must be no more than 25%, and (2) the sum of the weights of the top 5 positions must be no more than 50%.

#exchange #shares #section #contribute

Evommune, Inc. (NYSE:EVMN) announced on September 8 that EVO756 missed its primary endpoint in a randomized, double-blind, placebo-controlled Phase 2b trial involving 121 adults with moderate-to-severe atopic dermatitis. The primary measure was the percentage change from baseline in Eczema Area and Severity Index, or EASI, at week 12. No tested dose met the primary or secondary endpoints, and development in that indication will stop.
Evommune, Inc. (NYSE:EVMN) had already discontinued EVO756 for chronic spontaneous urticaria following a June trial failure. Development continues in migraine prevention. The setbacks place greater weight on EVO301, which has positive Phase 2a eczema data and a Phase 2b study planned for mid-2027.
Evommune, Inc. (NYSE:EVMN) has clinical evidence supporting its next eczema program. In February, the company reported that EVO301 met the primary endpoint in a randomized, double-blind, placebo-controlled Phase 2a trial involving 70 adults. Participants received two intravenous doses or placebo over a 12-week study.
Evommune, Inc. (NYSE:EVMN) reported a 55% EASI reduction with EVO301 versus 22% with placebo at week 12, a difference of 33 percentage points. The study met its prespecified Bayesian success criterion, and a separate conventional ****** ysis showed statistical significance at p

The Federal Reserve raised its benchmark interest rate by a quarter percentage point on Wednesday, the first increase since July 2023, with Fed Chair Kevin Warsh saying inflation has been "too high ... for too long."
The decision, reached by a unanimous 12-0 vote of the Federal Open Market Committee, brings the federal funds rate to a new target range of 3.75%–4%. The Fed's post-meeting statement pointed to persistent price pressures and a durable economy, declaring: "Inflation remains elevated. Today's policy action will support a timelier return to the Committee's 2 percent goal. The Committee will deliver price stability."
At a news conference following the decision, Warsh said the Fed needed to be confident "that underlying inflation is moving to our objective clearly and at sufficient speed," adding that the FOMC had determined "this standard has not been satisfied." He pointed to three converging factors — a robust labor market, inflation still running above target, and ongoing conflict in the Middle East — as driving the committee's unanimous vote.
The Dow Jones Industrial Average shed more than 400 points in afternoon trading following the Fed's move. The S&P 500 and the tech-heavy Nasdaq Composite also slumped.
Updated economic projections released Wednesday showed FOMC participants nudged their inflation forecasts higher. The median projection for headline PCE inflation this year rose to 3.7% and core PCE to 3.4%, each up 0.1 percentage point from the June forecast, the Fed said. Officials do not expect inflation to return to the 2% target until 2029. The median unemployment rate projection for 2026 fell to 4.1%, down from 4.3% in June, while the GDP growth outlook rose to 2.3% from 2.2%.

#federal #rate #committee

Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' experimental Lyme disease vaccine candidate, and will now begin the official review.
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.

#vaccine #pfizer #NYSE

Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' experimental Lyme disease vaccine candidate, and will now begin the official review.
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.

#disease

BECKLEY, WV (WVNS) - Volunteers have started planning for the return of the Beckley 5k and Half Marathon event.
Community groups get involved at Beckley's Kids Classic Festival
Members of Active Southern West Virginia have partnered with the Beckley-Raleigh County Chamber of Commerce to present the race.

Participants will start and finish at the Beckley Exhibition Coal Mine. Top place finishers could even walk away with a medal for their efforts! Organizers said all proceeds raised will go to a good cause.
"All the funds raised from this and other Active Southern West Virginia events help us to offer free community activities - things like workplace wellness, our kids' run club in schools," said Jenni Canterbury, Development Director with Active Southern West Virginia."
The half marathon is scheduled to kick off at 8:00 the morning of Saturday, September 26th, while the 5k will get started at 8:30 the same morning.

Those interested can go online for more details including information on how to register and how to get involved with volunteering on event day.

#beckley #southern

Detroit Lions first-round pick Blake Miller gained a reputation at Clemson for being an iron man. In three years in college, he didn't miss a single game, starting 54 consecutive contests.
When the Lions' injury report dropped on Monday, it appeared Miller's NFL streak could be broken after just one game. With only a walkthrough practice, Miller was estimated as a non-participant with a knee injury. And with Detroit on a short week—scheduled to play the Bills on the road this Thursday—it could be too quick of a turnaround to make the field.
However, the rookie right tackle spoke with the media after practice and sounded more optimistic about his chances of playing due to progress already made on Monday.
"I'm doing everything I humanly can to get my body feeling the best it can feel. Even with the progress just today that I've made, I'm happy, and I'm optimistic," Miller said.
Lions coach Dan Campbell said it was possible Miller could play vs. the Bills, but he was a little more cautious in his optimism.

#bills #game #practice